查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888649

医疗保健合约销售组织市场规模、份额和趋势分析报告：按服务、治疗领域、最终用途、地区和细分市场预测（2025-2033 年）

Healthcare Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal Promotion), By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医疗保健合约销售组织市场摘要

2024年全球医疗保健合约销售组织市场规模估计为112.1亿美元，预计到2033年将达到218.1亿美元。

预计从 2025 年到 2033 年，该市场将以 7.87% 的复合年增长率成长。推动该市场成长的因素有很多，包括对专科和创新药物的需求不断增长、技术进步和数位转型，以及医疗保健公司越来越重视扩大产品分销管道。

全球医疗市场正朝着个人化和专业化方向发展，包括生物製药、癌症治疗和罕见疾病药物，这是推动市场成长的因素之一。满足创新药物的需求需要一支训练有素、专注于特定领域的销售团队。因此，製药公司依靠具备专业治疗知识和先进沟通能力的临床负责人（CSO）来有效地向医疗专业人员传达复杂的产品讯息。这使得CSO的职责范围扩大到教育和宣传活动、上市后支援以及数位互动等领域。

此外，人工智慧 (AI)、客户关係管理 (CRM) 工具和数位行销平台的整合正在彻底改变医疗保健产业的销售营运和推广绩效。例如，约 35% 的製药企业正在积极推动更广泛的数位转型 (DX)倡议，以提高效率和创新能力。掌握这些技术的首席销售长 (CSO) 可以提供数据驱动的洞察，优化销售团队的生产力，并透过多通路策略增强客户参与。这种数位化转型降低了成本并提高了效率，使 CSO 成为现代製药公司不可或缺的合作伙伴。此外，虚拟推广和分析驱动型目标定位的应用，拓展了 CSO 的角色，使其超越了传统的销售运营，从而巩固了其在日益技术驱动的医疗保健生态系统中的地位。

此外，全球医疗保健和製药行业日益激烈的竞争促使企业寻求创新策略，以扩大产品覆盖范围并最大限度地提高收入潜力。随着新的治疗方法和医疗技术进入市场，医疗保健公司面临着在各种医疗保健系统中实现快速推广和广泛应用的压力。这导致与合约销售组织 (CSO) 的合作激增，CSO 提供专业且扩充性的销售团队以及强大的本地市场洞察力。 CSO 帮助企业进入竞争激烈的市场，提高产品知名度，并与医疗保健专业人员保持持续互动。因此，医疗保健公司日益重视以销售主导的倡议，持续推动全球对合约销售服务的需求。

目录

第一章调查方法和范围

第二章执行摘要

3. 医疗保健合约销售组织市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 科技趋势
  • 定价模式分析
  • 关税影响分析
  • 市场分析工具
    • 波特五力分析
    • PESTEL 分析与 SWOT 分析

第四章：医疗保健合约销售组织市场：按服务分類的估算和趋势分析

  • 医疗保健合约销售组织市场：按服务类型分類的波动分析
  • 医疗保健合约销售组织市场按服务分類的估算和预测，2021-2033年
  • 个人晋升
    • 促销销售团队
    • 重点客户管理
    • 职缺管理
  • 非个人推广
    • 医疗事务解决方案
    • 远端医疗科学联络员
    • 护理师（临床）负责人
    • 其他的

第五章：医疗保健合约销售组织市场：按治疗领域分類的估算和趋势分析

  • 医疗保健合约销售组织市场：按治疗领域分類的波动分析
  • 2021-2033年按治疗领域分類的医疗保健合约销售组织市场估算与预测
  • 肿瘤学
  • 循环系统疾病
  • 神经病学
  • 感染疾病
  • 代谢性疾病
  • 整形外科疾病
  • 其他的

第六章：医疗保健合约销售组织市场：依最终用途分類的估算与趋势分析

  • 医疗保健合约销售组织市场：按最终用途分類的差异分析
  • 医疗保健合约销售组织市场按最终用途分類的估算和预测，2021-2033年
  • 製药公司
  • 生物製药公司
  • 医疗设备製造商

第七章：医疗保健合约销售组织市场：区域估算与趋势分析

  • 区域市场概览
  • 区域市场占有率分析（2024 年和 2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 科威特
    • 卡达
    • 阿曼

第八章 竞争情势

  • 主要参与企业分类
  • 2024年市场占有率/评估分析（热力图分析）
  • 公司简介
    • CMIC HOLDINGS Co., LTD.
    • Axxelus
    • EPS Corporation.
    • IQVIA Inc.
    • Publicis Group
    • MaBico
    • Syneos Health.
Product Code: GVR-4-68040-042-5

Healthcare Contract Sales Organizations Market Summary

The global healthcare contract sales organizations market size was estimated at USD 11.21 billion in 2024 and is projected to reach USD 21.81 billion by 2033, growing at a CAGR of 7.87% from 2025 to 2033. The market is advancing due to several factors, including the growing demand for specialty and innovative drugs, technological advancements and digital transformation, and the increasing interest of healthcare companies in expanding product sales.

Increasing global shift toward personalized and specialty medicines such as biologics, oncology therapies, and rare disease treatments is one of the factors driving market growth. Meeting the demand for innovative medicines requires highly trained, niche-focused salesforces. Thus, pharmaceutical companies rely on CSOs with specialized therapeutic knowledge and advanced engagement capabilities to effectively communicate complex product information to healthcare professionals. This has led to expanded roles for CSOs in educational outreach, post-launch support, and digital engagement.

Furthermore, the integration of artificial intelligence (AI), customer relationship management (CRM) tools, and digital marketing platforms is revolutionizing performance in healthcare sales and outreach. For instance, about 35% of drug manufacturers are adopting broader digital transformation initiatives to boost efficiency and innovation. CSOs adopting these technologies can deliver data-driven insights, optimize field force productivity, and enhance customer engagement through multichannel strategies. This digital transformation reduces costs and improves efficiency, making CSOs indispensable partners for modern pharmaceutical companies. Moreover, the use of virtual detailing and analytics-driven targeting has expanded the role of CSOs beyond traditional sales, strengthening their position in an increasingly tech-enabled healthcare ecosystem.

Moreover, intensifying competition in the global healthcare and pharmaceutical sectors has propelled companies to seek innovative strategies to expand their product reach and maximize revenue potential. As new therapies and medical technologies enter the market, healthcare firms face increasing pressure to achieve faster adoption and wider coverage across diverse healthcare systems. This has led to a surge in partnerships with contract sales organizations that offer specialized, scalable salesforces and strong local market expertise. CSOs help companies penetrate competitive markets, improve product visibility, and maintain consistent engagement with healthcare professionals. Thus, the growing sales-driven focus of healthcare firms continues to propel the demand for contract sales services worldwide.

Global Healthcare Contract Sales Organizations Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare contract sales organizations market report based on service, therapeutic area, end use, and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Personal Promotion
    • Promotional sales team
    • Key account management
    • Vacancy Management
  • Non - Personal Promotion
    • Medical Affairs Solutions
    • Remote Medical Science Liaisons
    • Nurse (Clinical) Educators
    • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular
  • Neurology
  • Infectious Diseases
  • Metabolic Disorders
  • Orthopedic Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical companies
  • Biopharmaceutical companies
  • Medical device companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Therapeutic Area
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Contract Sales Organizations Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Demand for Specialty and Innovative Drug
      • 3.2.1.2. Technological Advancements and Digital Transformation
      • 3.2.1.3. Growing Interest of Healthcare Companies to Increase the Sales of the Products
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Operational Costs
      • 3.2.2.2. Regulatory Complexity
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Healthcare Contract Sales Organizations Market: Service Estimates & Trend Analysis

  • 4.1. Healthcare Contract Sales Organizations Market, By Service: Segment Dashboard
  • 4.2. Healthcare Contract Sales Organizations Market, By Service: Movement Analysis
  • 4.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Personal Promotion
    • 4.4.1. Personal Promotion Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Promotional Sales Team
      • 4.4.2.1. Promotional Sales Team Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Key Account Management
      • 4.4.3.1. Key Account Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Vacancy Management
      • 4.4.4.1. Vacancy Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Non-Personal Promotion
    • 4.5.1. Non - Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Medical Affairs Solutions
      • 4.5.2.1. Medical Affairs Solutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Remote Medical Science Liaisons
      • 4.5.3.1. Remote Medical Science Liaisons Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Nurse (Clinical) Educators
      • 4.5.4.1. Nurse (Clinical) Educators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Contract Sales Organizations Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Healthcare Contract Sales Organizations Market, By Therapeutic Area: Segment Dashboard
  • 5.2. Healthcare Contract Sales Organizations Market, By Therapeutic Area: Movement Analysis
  • 5.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Neurology
    • 5.6.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Metabolic Disorders
    • 5.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Orthopedic Diseases
    • 5.9.1. Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Healthcare Contract Sales Organizations Market: End Use Estimates & Trend Analysis

  • 6.1. Healthcare Contract Sales Organizations Market, By End Use: Segment Dashboard
  • 6.2. Healthcare Contract Sales Organizations Market, By End Use: Movement Analysis
  • 6.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical companies
    • 6.4.1. Pharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharmaceutical companies
    • 6.5.1. Biopharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medical device companies
    • 6.6.1. Medical device companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Healthcare Contract Sales Organizations Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Saudi Arabia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Qatar
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Oman
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. CMIC HOLDINGS Co., LTD.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Axxelus
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. EPS Corporation.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. IQVIA Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Publicis Group
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. MaBico
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Syneos Health.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 6. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 8. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 10. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 20. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 23. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 32. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 33. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 35. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 42. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 44. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 51. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 63. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 64. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 69. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 70. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 73. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 76. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 84. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 89. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 90. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 97. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 99. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 100. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Healthcare Contract Sales Organizations Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Healthcare Contract Sales Organizations Market: Service Outlook and Key Takeaways
  • Fig. 20 Healthcare Contract Sales Organizations Market: Service Movement Analysis
  • Fig. 21 Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Promotional Sales Team Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Key Account Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Vacancy Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Non - Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Medical Affairs Solutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Remote Medical Science Liaisons Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Nurse (Clinical) Educators Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Healthcare Contract Sales Organizations Market: Therapeutic Area Outlook And Key Takeaways
  • Fig. 31 Healthcare Contract Sales Organizations Market: Therapeutic Area Movement Analysis
  • Fig. 32 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Healthcare Contract Sales Organizations Market: End Use Outlook And Key Takeaways
  • Fig. 40 Healthcare Contract Sales Organizations Market: End Use Movement Analysis
  • Fig. 41 Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Biopharmaceutical Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Medical Device Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 North America Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021-2033 (USD Million)
  • Fig. 46 Key Country Dynamics
  • Fig. 47 U.S. Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key Country Dynamics
  • Fig. 49 Canada Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 Mexico Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 UK Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Germany Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 France Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Italy Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Spain Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key Country Dynamics
  • Fig. 64 Denmark Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key Country Dynamics
  • Fig. 66 Sweden Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key Country Dynamics
  • Fig. 68 Norway Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Japan Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 China Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 India Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Australia Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Thailand Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 South Korea Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Brazil Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 Argentina Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Middle East & Africa Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 South Africa Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Saudi Arabia Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Kuwait Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Qatar Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key Country Dynamics
  • Fig. 99 Oman Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)